PeptideInjectableNootropicBioregulator peptide

Pinealon

Also known as EDR peptide · Glu-Asp-Arg

Written by enwyReviewed 5 Aug 20261 sources0 comments

Pinealon (Glu-Asp-Arg) is a synthetic tripeptide bioregulator from the Khavinson series, marketed as a nootropic and neuroprotective agent. Evidence is confined to preclinical rodent work and in vitro assays from its originating group; no controlled human trials exist.

01 Overview

Pinealon is one of Khavinson's short 'peptide bioregulators' claimed to target brain tissue. Rodent and cell studies from the developer report reduced oxidative-stress-induced neuronal apoptosis and improved learning measures, forming the basis of its nootropic marketing.\n\nThere is no independent human trial evidence. Sold as an injectable or nasal research peptide, its human dosing and safety are entirely anecdotal.

02 Mechanism

Proposed to penetrate cells and regulate gene expression in neurons, reducing oxidative-stress-mediated apoptosis; precise human mechanism unproven.

03 Dosing

Tier	Dose	Route	Notes
Anecdotal	5–10 mg/day	SubQ	Cycled courses per vendor anecdote; no clinical basis.

04 Effects

Effect	Magnitude	Evidence
NeuroprotectionReduced hypoxia/oxidative-stress-induced neuronal death in rodent and cell models.	n/a	Preclinical
Cognitive supportUsers report focus and mood benefits; unverified in humans.	n/a	Anecdotal

05 Side effects

Effect	Severity	Frequency	Evidence	Countermeasures
Injection-site reactionLocal irritation at subcutaneous sites.	Mild	Common	Anecdotal
Unknown human safetyNo human toxicology or long-term data available.	Moderate	Unquantified	Unconfirmed

06 Legal status

United States

Research chemical; not FDA-approved

Research use only. · as of Jan 2026

07 References

Short peptides regulate gene expression, protein synthesis and cell functionAdv Gerontol / Khavinson peptide reviews

08 Discussion0 comments

Create account

Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.

This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.